Chris Ison

Medlab approved to perform NSW medical marijuana trials

SHARE prices have shot up for the company chosen to carry out NSW's first medical marijuana trials.

Medlab Clinical listed on the ASX earlier this month before being granted approval on Wednesday to perform the clinical trials.

Share prices increased 5.41% to 19.5c by the day's close of trade and had yesterday risen to 20c.

In announcing it had won the contract, the company said it believed its "small particle delivery platform" could be used to administer smaller doses to reduce risks and complications to patients.

MORE: Australian-first medical cannabis trial starts next year

The NanoCelle vapour technology would allow the plant's chemicals to be used without the need for smoking.

"Further, the NanoCelle platform decreases the possibility of social misuse of the product," the statement said.

The NSW Government has pledged $9 million over four years to carry out the research, starting with 30 adult patients at a hospital in Newcastle.

It will also invest $12 million into a Centre for Cannabis Research and Innovation in an effort to become a global leader in the field.

Results from the study are expected early next year and will lead to broader studies across city and regional hospitals if deemed successful.

-APN NEWSDESK



With room to run free just Youwaitandsee

With room to run free just Youwaitandsee

Veteran Coffs Harbour trainer is hoping history can repeat tomorrow.

#Press for Progress on International Women's Day

#Press for Progress on International Women's Day

Call for Coffs Coast to embrace International Women's Day

Is a dolphin sea pen in the harbour the best option?

Is a dolphin sea pen in the harbour the best option?

Study to assess whether DMM dolphins can be rehoused in harbour

Local Partners